Down-regulation of a novel actin-binding molecule, skeletrophin, in malignant melanoma

American Journal of Pathology

Volumn 163, Issue 4, 2003, Pages 1395-1404

  Takeuchi, Tamotsu ^a   Heng, Henry H Q ^e   Ye, Christine J ^e   Liang, Sheng Ben ^b   Iwata, Jun ^c   Sonobe, Hiroshi ^d   Ohtsuki, Yuji ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c Kochi Municipal Central Hospital   (Japan)

^d Fukuyama City Hospital   (Japan)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; ANKYRIN; COMPLEMENTARY DNA; CYSTEINE; DYSTROPHIN; RNA; SKELETROPHIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; DOWN REGULATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MELANOMA; MOLECULAR CLONING; NEUROBLASTOMA CELL; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR SUPPRESSOR GENE; TWO HYBRID SYSTEM; ZINC FINGER MOTIF;

EID: 0141648464     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63497-9     Document Type: Article

References (35)

1. Takeuchi T, Nicole S, Misaki A, Furihata M, Iwata J, Sonobe H, Ohtsuki Y: Expression of SMARCF1, a truncated form of SWI1, in neuroblastoma. Am J Pathol 2001, 158:663-672
2. Henikoff S: Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene 1984, 28:351-359
3. Takeuchi T, Kuro-o M, Miyazawa H, Ohtsuki Y, Yamamoto H: Transgenic expression of a novel thymic epithelial cell antigen stimulates aberrant development of thymocytes. J Immunol 1997, 159:726-733
4. Takeuchi T, Misaki A, Liang S-B, Tachibana A, Hayashi N, Sonobe H, Ohtsuki Y: Expression of T-cadherin (CDH13, H-cadherin) in human brain and its characteristics as a negative growth regulator of EGF in neuroblastoma cells. J Neurochem 2000, 74:1489-1497
5. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76:4350-4354
6. Takeuchi T, Barcos MP, Seon BK: Monoclonal antibody SN10 which shows a highly selective reactivity with human B leukemia-lymphoma and is effectively internalized into cells. Cancer Res 1991, 51:2985-2993
7. Heng HHQ, Squire J, Tsui L-C: High resolution mapping of mammalian genes by in situ hybridization to free chromatin. Proc Natl Acad Sci USA 1992, 89:9509-9513
8. Heng HHQ, Tsui L-C: Models of DAPI banding and simultaneous in situ hybridization. Chromosoma 1993, 102:325-332
9. Takeuchi T, Liang S-B, Matsuyoshi N, Zhou S, Miyachi T, Sonobe H, Ohtsuki Y: Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma. Lab Invest 2002, 82:1023-1029
10. Ko L, Cardona GR, Iwasaki T, Bramlett KS, Burris TP, Chin WW: Ser-884 adjacent to the LXXLL motif of coactivator TRBP defines selectivity for ERs and TRs. Mol Endocrinol 2002, 16:128-140
11. Reisman DN, Strobeck MW, Betz BL, Sciariotta J, Funkhouser WJ, Murchardt C, Yaniv M, Sherman LS, Knudsen ES, Weissman BE: Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs. CD44 expression. Oncogene 2002, 21:1196-1207
12. Clark J, Rocques OJ, Crew AJ, Gill S, Shipley J, Chan A M-L, Gusterson BA, Cooper CS: identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 1994, 7:502-508
13. de Leeuw B, Balemans M, Olde Weghuis D, Seruca R, Janz M, Geraghty MT, Gilgenkrantz S, Ropers HH, Geurts van Kessel A: Molecular cloning of the synovial sarcoma-specific translocation (X; 18)(p11.2;q11.2) breakpoint. Hum Mol Genet 1994, 3:745-749
14. Crew AJ, Clark J, Fisher C, Gill S, Grimer R, Chand A, Shipley J, Gusterson BA, Cooper CS: Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Krüppel-associated box in human synovial sarcoma. EMBO J 1995, 14:2333-2340
15. Güre AO, Türeci O, Sahin U, Tsang S, Scanlan MJ, Jäger E, Knuth A, Pfreundschuh M, Old LJ, Chen Y-T: SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer 1997, 72:965-971
16. Kato H, Tjernberg A, Zhang W, Krutchinsky AN, An W, Takeuchi T, Ohtsuki Y, Sugano S, Chaii BT, Roeder RG: SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones. J Biol Chem 2002, 277:5498-5505
17. dos Santos NR, Torensma R, de Vries TJ, Schreurs MWJ, de Bruijn DRH, Kater-Baats E, Ruiter DJ, Adema GJ, van Muijen GNP, van Kessel AG: Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. Cancer Res 2000, 60:1654-1662
18. Türeci O, Sahin U, Schobert I, Koslowski M, Schmitt H, Schild H-J, Stenner F, Seitz G, Rammensee G, Pfreundschuh M: The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 1996, 56:4766-4772
19. Shapiro DN, Sublett JE, Li B, Valentine MB, Morris SW, Noll M: The gene for PAX7, a member of the paired-box-containing genes, is localized on human chromosome arm 1p36. Genomics 1993, 17:767-769
20. Bale SJ, Dracopoli NC, Tucker MA, Clark WH Jr, Fraser MC, Stanger BZ, Green P, Donis-Keller H, Housman DE, Greene MH: Mapping of the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med 1989, 320:1367-1372
21. Millikin D, Meese E, Vogelstein B, Witkowski C, Trent J: Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res 1991, 51:5449-5453
22. Cannon-Albright LA, Meyer LJ, Goldgar DE, Lewis CM, McWhorter WP, Jost M, Harrison D, Anderson DE, Zone JJ, Skolnick MH: Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res 1994, 54:6041-6044
23. Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, Speleman F, Fletchers CD, Aurias A, Thomas G: EWS and ATF-1 gene fusion induced by t(12:22) translocation in malignant melanoma of soft parts. Nat Genet 1993, 4:341-345
24. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP: Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res, 1998, 72:141-196
25. Ponting CP, Blake DJ, Davies KE, Kendrick-Jones J, Winder SJ: ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins. Trends Biochem Sci 1996, 21:11-13
26. Sudol M, Chen HI, Bougeret C, Einbond A, Bork P: Characterization of a novel protein-binding module: the WW domain. FEBS Lett 1995, 369:67-71
27. Tinsley JM, Blake DJ, Roche A, Byth BC, Knight AE, Kendrick-Jones J, Suthers GK, Love DR, Edwards YH, Davies KE: Primary structure of dystrophin-related protein. Nature 1992, 360:591-593
28. Kunkel LM, Monaco AP, Middlesworth W, Ochs HD, Latt SA: Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci USA 1985, 82:4778-4782
29. Hoffman EP, Brown RH, Kunkel LM: Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928
30. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM: An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988, 2:90-95
31. Anderson JT, Rogers RP, Jarrett HW: Ca2+-calmodulin binds to the carboxyl-terminal domain of dystrophin. J Biol Chem 1996, 271:6605-6610
32. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL: Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 1993, 90:3710-3714
33. Pasternak C, Wong S, Elson EL: Mechanical function of dystrophin in muscle cells. J Cell Biol 1995, 128:355-361
34. Bennett V: Ankyrins. J Biol Chem 1992, 267:8703-8706
35. Pollard TD, Blanchoin L, Mullins RD: Molecular mechanism controlling actin filament dynamics in nonmuscle cells. Annu Rev Biophys Biomol Struct 2000, 29:545-576